These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25009982)

  • 21. Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms.
    Hampel H
    J Alzheimers Dis; 2013; 33 Suppl 1():S79-86. PubMed ID: 22531423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic inflammation linking chronic periodontitis to cognitive decline.
    Wang RP; Ho YS; Leung WK; Goto T; Chang RC
    Brain Behav Immun; 2019 Oct; 81():63-73. PubMed ID: 31279681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study.
    Cribbs DH; Berchtold NC; Perreau V; Coleman PD; Rogers J; Tenner AJ; Cotman CW
    J Neuroinflammation; 2012 Jul; 9():179. PubMed ID: 22824372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease.
    Soldan A; Pettigrew C; Cai Q; Wang J; Wang MC; Moghekar A; Miller MI; Albert M;
    Neurobiol Aging; 2017 Dec; 60():164-172. PubMed ID: 28968586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular and cellular aspects of age-related cognitive decline and Alzheimer's disease.
    Hullinger R; Puglielli L
    Behav Brain Res; 2017 Mar; 322(Pt B):191-205. PubMed ID: 27163751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modelling Decline in Cognition to Decline in Function in Alzheimer's Disease.
    Karcher H; Savelieva M; Qi L; Hummel N; Caputo A; Risson V; Capkun G; Alzheimer's Disease Neuroimaging Initiative
    Curr Alzheimer Res; 2020; 17(7):635-657. PubMed ID: 33032508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dogs with Cognitive Dysfunction as a Spontaneous Model for Early Alzheimer's Disease: A Translational Study of Neuropathological and Inflammatory Markers.
    Schütt T; Helboe L; Pedersen LØ; Waldemar G; Berendt M; Pedersen JT
    J Alzheimers Dis; 2016 Mar; 52(2):433-49. PubMed ID: 27003213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of education on the progression of early- versus late-stage mild cognitive impairment.
    Ye BS; Seo SW; Cho H; Kim SY; Lee JS; Kim EJ; Lee Y; Back JH; Hong CH; Choi SH; Park KW; Ku BD; Moon SY; Kim S; Han SH; Lee JH; Cheong HK; Na DL
    Int Psychogeriatr; 2013 Apr; 25(4):597-606. PubMed ID: 23207181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
    Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
    J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telomere shortening reflecting physical aging is associated with cognitive decline and dementia conversion in mild cognitive impairment due to Alzheimer's disease.
    Koh SH; Choi SH; Jeong JH; Jang JW; Park KW; Kim EJ; Kim HJ; Hong JY; Yoon SJ; Yoon B; Kang JH; Lee JM; Park HH; Ha J; Suh YJ; Kang S
    Aging (Albany NY); 2020 Mar; 12(5):4407-4423. PubMed ID: 32126022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease.
    Sattlecker M; Khondoker M; Proitsi P; Williams S; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Dobson RJ
    J Alzheimers Dis; 2016; 49(4):1105-14. PubMed ID: 26599049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
    Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
    Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered function of neuronal L-type calcium channels in ageing and neuroinflammation: Implications in age-related synaptic dysfunction and cognitive decline.
    Navakkode S; Liu C; Soong TW
    Ageing Res Rev; 2018 Mar; 42():86-99. PubMed ID: 29339150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease.
    Lueg G; Gross CC; Lohmann H; Johnen A; Kemmling A; Deppe M; Groger J; Minnerup J; Wiendl H; Meuth SG; Duning T
    Neurobiol Aging; 2015 Jan; 36(1):81-9. PubMed ID: 25277040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors.
    Musicco M; Palmer K; Salamone G; Lupo F; Perri R; Mosti S; Spalletta G; di Iulio F; Pettenati C; Cravello L; Caltagirone C
    J Neurol; 2009 Aug; 256(8):1288-95. PubMed ID: 19353221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index.
    Davatzikos C; Xu F; An Y; Fan Y; Resnick SM
    Brain; 2009 Aug; 132(Pt 8):2026-35. PubMed ID: 19416949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age.
    Betthauser TJ; Koscik RL; Jonaitis EM; Allison SL; Cody KA; Erickson CM; Rowley HA; Stone CK; Mueller KD; Clark LR; Carlsson CM; Chin NA; Asthana S; Christian BT; Johnson SC
    Brain; 2020 Jan; 143(1):320-335. PubMed ID: 31886494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging.
    Friedman JI; Harvey PD; Coleman T; Moriarty PJ; Bowie C; Parrella M; White L; Adler D; Davis KL
    Am J Psychiatry; 2001 Sep; 158(9):1441-8. PubMed ID: 11532729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inter-network connectivity and amyloid-beta linked to cognitive decline in preclinical Alzheimer's disease: a longitudinal cohort study.
    Van Hooren RWE; Riphagen JM; Jacobs HIL;
    Alzheimers Res Ther; 2018 Aug; 10(1):88. PubMed ID: 30153858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.